logo
Select company
Select metric
$ 0Net Income to Non-Controlling Interests
VS
Market
10
Sector
8
Industry
7
History
-
$ 15.57Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information

Ticker

SNDX

Company Name

SYNDAX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SYNDAX PHARMACEUTICALS INC - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SNDX - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) Net Inc. NCI stands at $ 3.91M.
  • Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average Net Inc. NCI has been $ 390.6K.
  • The median Net Inc. NCI for SYNDAX PHARMACEUTICALS INC during this period was $ 0
  • SYNDAX PHARMACEUTICALS INC reached its highest Net Inc. NCI over the past 5 years at $ 3.91M.
  • The lowest Net Inc. NCI recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe $ 0

SYNDAX PHARMACEUTICALS INC's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
NRIX : NURIX THERAPEUTICS INC $ 0URGN : UROGEN PHARMA LTD $ 0TBPH : THERAVANCE BIOPHARMA INC $ 0ZVRA : ZEVRA THERAPEUTICS INC $ 0KURA : KURA ONCOLOGY INC $ 0SAGE : SAGE THERAPEUTICS INC $ 0GYRE : GYRE THERAPEUTICS INC $ 4.57MNKTR : NEKTAR THERAPEUTICS $ 0EYPT : EYEPOINT PHARMACEUTICALS INC $ 0ZYME : ZYMEWORKS INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

SNDX - Net Income to Non-Controlling Interests, Last 5 years

$ 0

Minimum

Mar 31, 2021

$ 3.91M

Maximum

Sep 30, 2020

$ 390.6K

Average

$ 0

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.09M with a standard deviation of $ 136.42M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.27K
min$ -1.8B
max$ 2.94B
average$ 11.09M
median$ 0
std$ 136.42M